Hilary Mcelwaine-Johnn

A highly experienced Chief Medical Officer, graduate of Imperial College and St Mary’s Hospital Medical School, London, Member of the Royal College of Physicians and Faculty of Pharmaceutical Medicine. 25+ years of drug development experience including PowderMed, PsiOxus Therapeutics and Karus Therapeutics.